<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zarifyan, Alla</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Broderick, Joseph P.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Endovascular Intervention Beneficial in Pooled Analysis of MR CLEAN and IMS III</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-03-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">11-11</style></pages><abstract><style  face="normal" font="default" size="100%">A pooled analysis of MR CLEAN and IMS III trial data from the patient subgroup with National Institutes of Health Stroke Scale score ≥ 20 demonstrated the benefit of endovascular therapy in addition to intravenous tissue plasminogen activator treatment in patients presenting with severe stroke.</style></abstract><number><style face="normal" font="default" size="100%">2</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>